Xu B - Search Results

1

Novel method for isolation of adult porcine pancreatic islets with two-stage digestion procedure.

Cui W, Gu Y, Miyamoto M, Tanaka M, Xu B, Imamura M, Iwata H, Ikada Y, Inoue K. Cui W, et al. Among authors: xu b. Cell Transplant. 1999 Jul-Aug;8(4):391-8. doi: 10.1177/096368979900800408. Cell Transplant. 1999. PMID: 10478719 Free article.

2

Development of a new bioartificial pancreas possessing angiogenesis-inducing function.

Gu YJ, Cui WX, Miyamoto M, Kawakami Y, Xu BY, Balamurugan AN, Nagata N, Morimoto Y, Imamura M, Satake A, Iwata H, Nozawa M, Inoue K. Gu YJ, et al. Among authors: xu by. Transplant Proc. 2000 Nov;32(7):2475. doi: 10.1016/s0041-1345(00)01751-6. Transplant Proc. 2000. PMID: 11120252 No abstract available.

3

Effect of neovascularization-inducing bioartificial pancreas on survival of syngeneic islet grafts.

Gu YJ, Miyamoto M, Cui WX, Xu BY, Kawakami Y, Yamasaki T, Setoyama H, Kinosita N, Iwata H, Ikada Y, Imamura M, Inoue K. Gu YJ, et al. Among authors: xu by. Transplant Proc. 2000 Nov;32(7):2494-5. doi: 10.1016/s0041-1345(00)01763-2. Transplant Proc. 2000. PMID: 11120263 No abstract available.

4

Establishment of fluorescein diacetate and ethidium bromide (FDAEB) assay for quality assessment of isolated islets.

Miyamoto M, Morimoto Y, Nozawa Y, Balamurugan AN, Xu B, Inoue K. Miyamoto M, et al. Among authors: xu b. Cell Transplant. 2000 Sep-Oct;9(5):681-6. doi: 10.1177/096368970000900514. Cell Transplant. 2000. PMID: 11144965 Free article.

5

Development of a cryopreservation procedure employing a freezer bag for pancreatic islets using a newly developed cryoprotectant.

Miyamoto M, Balamurugan AN, Nozawa Y, Sakurai T, Xu B, Yoshimura S, Tanaka T, Tohyama T, Miyakoshi J, Inoue K. Miyamoto M, et al. Among authors: xu b. Cell Transplant. 2001;10(4-5):363-71. Cell Transplant. 2001. PMID: 11549055

6

Functional comparison of the single-layer agarose microbeads and the developed three-layer agarose microbeads as the bioartificial pancreas: an in vitro study.

Xu B, Iwata H, Miyamoto M, Balamurugan AN, Murakami Y, Cui W, Imamura M, Inoue K. Xu B, et al. Cell Transplant. 2001;10(4-5):403-8. Cell Transplant. 2001. PMID: 11549062

7

The influence of the anticomplement synthetic sulfonic polymers on the function of pancreatic islets: an in vitro study.

Xu B, Gu Y, Miyamoto M, Balamurugan AN, Cui W, Imamura M, Iwata H, Inoue K. Xu B, et al. Cell Transplant. 2001;10(4-5):413-7. Cell Transplant. 2001. PMID: 11549064

8

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Among authors: xu f. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.

9

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Geyer CE Jr, et al. Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10. Ann Oncol. 2022. PMID: 36228963 Free PMC article. Clinical Trial.

10

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial.

Hurvitz SA, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Egorov A, Liu Y, Cathcart J, Bako E, Tecson K, Verma S, Cortés J. Hurvitz SA, et al. Among authors: xu b. ESMO Open. 2024 May;9(5):102924. doi: 10.1016/j.esmoop.2024.102924. Epub 2024 Apr 24. ESMO Open. 2024. PMID: 38796287 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,046 results

Search Page

Filters